Product logins

Find logins to all Clarivate products below.


The US ENT device market will grow modestly over the forecast period, fueled by slight growth in ENT procedure volumes that will be partially supported by the shift toward outpatient and office-based settings, as well as the fee-for-service payment model for most ENT procedures. Relatively faster expansion will be seen in the ENT RF and powered instrument, balloon dilation device, and nasal packing device segments. 

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for ENT devices in the US from 2019 through 2033.

Related Medtech Insights Reports

Report
Pain Management Devices – Market Insights – US
The US pain management device market is driven by continuous product innovation aimed at enhancing treatment efficacy and addressing new indications. Favorable clinical evidence and pain management…
Report
Spinal Implants – Market Insights – United States
The US spinal implant market is projected to grow steadily, despite being limited by declining ASPs. This growth will be supported by favorable demographic trends, such as an aging population, and…
Report
Heart Valve Devices – Market Insights – United States
The US heart valve device market has seen rapid shifts in market dynamics, from renewed growth in the surgical heart valve device segment to the introduction of novel products and key approvals of…
Report
Pain Management Devices – Market Insights – Europe
The European pain management space remains active, with manufacturers continuing to innovate and work toward receiving regulatory approval for new indications, supporting market growth in Europe…
Report
Heart Valve Devices | Market Insights | US | 2024
The US heart valve device market will continue to experience rapid growth, largely driven by the adoption of THV devices. Clinical investigations continue to generate positive results and propel…